DE415693T1 - Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit. - Google Patents

Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit.

Info

Publication number
DE415693T1
DE415693T1 DE199090309368T DE90309368T DE415693T1 DE 415693 T1 DE415693 T1 DE 415693T1 DE 199090309368 T DE199090309368 T DE 199090309368T DE 90309368 T DE90309368 T DE 90309368T DE 415693 T1 DE415693 T1 DE 415693T1
Authority
DE
Germany
Prior art keywords
opiate
dependency
composition
reducing
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE199090309368T
Other languages
English (en)
Inventor
Frank C/O The University Of Arizon Tucson Arizona 85724 Us Porreca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARIZONA TECHNOLOGY DEVELOPMENT CORP TUCSON ARIZ US
Original Assignee
ARIZONA TECHNOLOGY DEVELOPMENT CORP TUCSON ARIZ US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARIZONA TECHNOLOGY DEVELOPMENT CORP TUCSON ARIZ US filed Critical ARIZONA TECHNOLOGY DEVELOPMENT CORP TUCSON ARIZ US
Publication of DE415693T1 publication Critical patent/DE415693T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE199090309368T 1989-08-28 1990-08-28 Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit. Pending DE415693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39959089A 1989-08-28 1989-08-28

Publications (1)

Publication Number Publication Date
DE415693T1 true DE415693T1 (de) 1991-10-17

Family

ID=23580136

Family Applications (1)

Application Number Title Priority Date Filing Date
DE199090309368T Pending DE415693T1 (de) 1989-08-28 1990-08-28 Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit.

Country Status (3)

Country Link
EP (1) EP0415693A1 (de)
JP (1) JPH03163030A (de)
DE (1) DE415693T1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5985880A (en) 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5472943A (en) * 1992-09-21 1995-12-05 Albert Einstein College Of Medicine Of Yeshiva University, Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
US5512578A (en) * 1992-09-21 1996-04-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
US6096756A (en) 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE69413933T2 (de) * 1993-06-30 1999-04-08 Toray Industries Antitussiva
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6107330A (en) * 1995-08-07 2000-08-22 Daiichi Pharmaceutical Co., Ltd. Inhibitor for narcotic analgesic dependence/resistance acquisition
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
IL149352A0 (en) 1999-10-29 2002-11-10 Euro Celtique Sa Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
JP2004512354A (ja) 2000-10-30 2004-04-22 ユーロ−セルティーク，エス．エイ． ヒドロコドン放出制御製剤
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361553A (en) * 1981-05-18 1982-11-30 Regents Of The University Of California Therapeutic uses of dynorphin
EP0381696B1 (de) * 1987-10-07 1993-07-28 Matrix Technologies, Inc. Pharmazeutische zusammensetzung für die behandlung der kokainsucht

Also Published As

Publication number Publication date
EP0415693A1 (de) 1991-03-06
JPH03163030A (ja) 1991-07-15

Similar Documents

Publication Publication Date Title
DE415693T1 (de) Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit.
DE3585041D1 (de) Verfahren zur haertung von organopolysiloxanzusammensetzungen und organopolysiloxanzusammensetzungen.
DE69424591D1 (de) Verfahren zur Kontrolle der Datenmenge und Kodierer zur Durchführung desselben.
DE3785329T2 (de) Harzzusammensetzung und verfahren zur herstellung.
DE69407624D1 (de) Verfahren zur herstellung von sialon-verbundwerkstoffen
DE69113025T2 (de) Drei neue nichtpolyglutamisierende deazaaminopterine und verfahren zur herstellung.
ATA124894A (de) Verfahren zur direktreduktion von eisenoxidhältigem material
DE59406145D1 (de) Verfahren zur gewinnung von adsorptionsmaterial
DE69422812T2 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan und/oder 1,1,3,3,3-pentafluorpropen
DE68912187T2 (de) Zusammensetzung für und Verfahren zur Leimung.
DE69103152T2 (de) Zusammensetzung und verfahren zur chromatierung von metallen.
DE69430703D1 (de) Verfahren zur korrektur der dicke von exzessiven aushärtenden, photometrisch geformten gegenständen
DE59407708D1 (de) Verfahren zur herstellung von homo- und copolymerisaten von alk-1-enen
DE68902787T2 (de) Verfahren zur reduktion von carbonylverbindungen.
DE69100870T2 (de) Verfahren und Zusammensetzung zur Verhinderung der Kesselsteinbildung.
DE69114564T2 (de) Verfahren zur Härtung von Methylhydrogensiloxanen.
DE59507436D1 (de) Verfahren zur direktreduktion von eisenoxidhältigem material
DE69836083D1 (de) Verfahren zur kaskadierung von v5 schnittstellen
DE69314644T2 (de) Verfahren zur isomerisierung von 1,1,2-trichlortrifluorethan
DE69419516D1 (de) Verfahren zur herstellung von hexafluorocyclobuten und verfahren zur herstellung von hexafluorocyclobutan
DE3851062D1 (de) Verfahren und zusammensetzung zur härtung von gelatinezusammensetzungen.
DE58904629D1 (de) Verfahren zur reduktiven enthalogenierung von aromaten.
DE3851541D1 (de) Propylen-äthylen-kopolymer-zusammensetzung und verfahren zur herstellung.
DE59503391D1 (de) Verfahren zur direktreduktion von eisenoxidhältigem material
ATA155994A (de) Verfahren zur herstellung von calciumcarbid